ENOV vs ESTA: stock comparison and AI forecast
Enovis Corp (ENOV) and Establishment Labs Holdings Inc. (ESTA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ENOV Enovis Corp
- Market Cap
- $1.20B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ESTA Establishment Labs Holdings Inc.
- Market Cap
- $1.83B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ESTA is 1.5 times larger than ENOV by market capitalization ($1.83B against $1.20B).
- ESTA turns -15.8% of its revenue into net income, against -48.0% for ENOV.
- ESTA carries 15.29 times debt per unit of equity, against 1.55 times for ENOV.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ENOV | ESTA |
|---|---|---|
| Market Cap | $1.20B | $1.83B |
| P/B Ratio | 0.82x | 84.69x |
| EPS | $-20.13 | $-1.54 |
| Book Value/Share | $25.61 | $0.73 |
| Revenue/Share | $39.82 | $8.25 |
| FCF/Share | $1.10 | $-1.39 |
Profitability & Margins
| Metric | ENOV | ESTA |
|---|---|---|
| ROE | -74.6% | -180.0% |
| ROA | -29.2% | -11.1% |
| ROIC | -32.9% | -6.5% |
| Gross Margin | 61.1% | 70.5% |
| Operating Margin | -45.1% | -7.6% |
| Net Margin | -48.0% | -15.8% |
| EBT Margin | -46.5% | -19.3% |
| Tax Rate | -2.9% | 18.1% |
Financial Health
| Metric | ENOV | ESTA |
|---|---|---|
| Current Ratio | 1.98x | 3.84x |
| Quick Ratio | 1.00x | 2.52x |
| D/E Ratio | 1.55x | 15.29x |
| Financial Leverage | 2.55x | 16.29x |
| Interest Coverage | 2.2x | -1.1x |
| Working Capital | $603M | $183M |
Cash Flow
| Metric | ENOV | ESTA |
|---|---|---|
| Operating Cash Flow | $270M | -$32M |
| Free Cash Flow | $64M | -$42M |
| Capital Spending | -$206M | -$9M |
| OCF Growth YoY | 43.6% | – |
| FCF/Sales | 2.8% | -16.9% |
| CapEx/Sales | 9.0% | 3.7% |
Operational Efficiency
| Metric | ENOV | ESTA |
|---|---|---|
| Asset Turnover | 0.61x | 0.70x |
| Receivables Turnover | 5.2x | 3.2x |
| Inventory Turnover | 1.5x | 0.8x |
| Fixed Assets Turnover | 4.3x | 3.3x |
| Days Sales Outstanding | 70 days | 112 days |
| Days Inventory | 246 days | 428 days |
| Payables Period | 79 days | 165 days |
| Cash Conversion Cycle | 237 days | 375 days |
Income Statement
| Metric | ENOV | ESTA |
|---|---|---|
| Total Revenue | $2.30B | $246M |
| Operating Income | -$1.04B | -$19M |
| Net Income | -$1.10B | -$39M |
| R&D Expense | $124M | $20M |
| SG&A Expense | $1.08B | $172M |
| Cost of Goods Sold | $894M | $73M |
Dividend & Shareholder Information
| Metric | ENOV | ESTA |
|---|---|---|
| Shares Outstanding | 58M | 30M |
ENOV vs ESTA: stock comparison and AI forecast
Which is bigger, ENOV or ESTA?
ESTA is 1.5 times larger than ENOV by market capitalization ($1.83B against $1.20B).
Which one does Intratio's AI model rank higher, ENOV or ESTA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.